BPZE1: Completed Phase Ib enrollment

ILiAD said INSERM completed enrollment of healthy volunteers in a single-blind, placebo-controlled, dose-escalation, Swedish Phase Ib trial of single doses of intranasal BPZE1. ILiAD in-licensed the v...